Company / Operating Cash Flow per Share
Fortress Biotech, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.87
FY2025
5-year range
-$24.35 / -$0.88
FY2021-FY2025
Trend
+66.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-24.35 in FY2023 to $-0.35 in FY2016.
Based on SEC 10-K filings.
-2.87 in FY2025.
Improved from $-24.35 to $-2.87 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 66.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.87 | +66.2% |
| FY2024 | -$8.50 | +65.1% |
| FY2023 | -$24.35 | -2019.8% |
| FY2022 | -$1.15 | -30.3% |
| FY2021 | -$0.88 | +31.2% |
| FY2020 | -$1.28 | +24.9% |
| FY2019 | -$1.71 | -7.2% |
| FY2018 | -$1.59 | -282.9% |
| FY2017 | -$0.42 | -20.2% |
| FY2016 | -$0.35 | +45.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026